AKT1 and glioblastoma: Cellular component (CC) enrichment identified key complexes such as the serine/threonine protein kinase complex, phosphotransferase complex, and receptor complex, suggesting that DET’s anti-tumor effects in GBM are linked to its influence on phosphotransferase functions, protein kinase activity, and kinase regulation (Figure 3B).